Skip to content

CNTN CNTN Proceeds From Issuance Of Common Stock Upon Atthemarket Offerings

Proceeds From Issuance Of Common Stock Upon Atthemarket Offerings at other companies

Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$137.09M
Bit Digital logo
Bit DigitalBTBT
$4.11M-59.6%
Ethos Technologies, Inc.
 logo
Ethos Technologies, Inc. LIFE
$0-100%
Bit Digital logo
Bit DigitalBTBT
$4.11M-59.6%
Spyre Therapeutics, Inc. logo
Spyre Therapeutics, Inc.SYRE
$9.75M
Energous logo
EnergousWATT
$31.87M+131%

Other financials

Income statement

See full
Operating income-$36.9M-1,348%
Net income-$47.3M-1,763%
EPS (diluted)-$0.23+76.8%

Balance sheet

See full
Cash & equivalents$41.5M+3,760%
Total debt$1.4M0.0%
Total equity$469.8M+57,767%
Total assets$584.7M+35,093%

Cash flow

See full
Operating cash flow-$7.6M-184%

Valuation

See full
Market cap$217.49M+8.0%

Returns & leverage

See full
Return on equity-18%-8.6pp
Debt / equity0.3×
Current ratio37.7×+37.1×

Where this comes from

Reported directly by CNTN in its filing.

Tagged under the XBRL concept CNTN:ProceedsFromIssuanceOfCommonStockUponAtthemarketOfferings.

The official record: CNTN’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about CNTN's proceeds from issuance of common stock upon atthemarket offerings.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CNTN's proceeds from issuance of common stock upon atthemarket offerings?
CNTN (CNTN) reported proceeds from issuance of common stock upon atthemarket offerings of $35.53M in Q1 2026.
How has CNTN's proceeds from issuance of common stock upon atthemarket offerings changed year-over-year?
CNTN's proceeds from issuance of common stock upon atthemarket offerings increased by 2488.8% year-over-year, from $1.37M to $35.53M.
What does proceeds from issuance of common stock upon atthemarket offerings mean?
Reflects the cash inflow from selling common stock incrementally into the market at prevailing prices, often referred to as an 'at-the-market' offering. This provides a flexible mechanism for the company to raise capital without the need for a formal, large-scale underwriting event.